Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
Evaluate the Safety and Efficacy of Fespixon Cream for the Treatment of Chronic Diabetic Foot
Ulcers (TEXAS 1A, 2A) in dialysis patients This study aimed to evaluate the effects of a
topical cream containing Plectranthus amboinicus and Centella Asiatica when applied topically
to diabetic foot ulcers in uremia patients with PAOD.